Sofia Gkountela

Sofia Gkountela is an accomplished scientist with extensive experience in target and discovery biology, currently serving as Associate Director at Monte Rosa Therapeutics since December 2022. Prior to this role, Sofia was a Senior Principal Scientist at the Novartis Institutes for BioMedical Research (NIBR) Oncology, where contributions included developing assays for targeted protein degradation and understanding the relationship between pharmacokinetics/pharmacodynamics and efficacy. Additional experience includes research at the University of Basel, focusing on circulating tumor cells and cancer metastasis, as well as postdoctoral work at UCLA and Uppsala University, where Sofia advanced methodologies in cell isolation and gene therapy for cancer. Sofia holds a Ph.D. in Molecular Microbiology and a B.S. in Biology from the National and Kapodistrian University of Athens.